SilicoGenesis

The AI engine Fit Assessment

Beta

SilicoGenesis leverages advanced machine learning technologies to discover new patterns and expand therapeutic options, optimizing the drug discovery process effectively.

Blurb

SilicoGenesis is a biotechnology research firm that specializes in developing antibodies.

HQ Location

Belgium

Founded

2021

Employees

1 - 10

Total funding raised

Not available

Last Funding Event

Not available

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Drug Discovery Optimization

Operator of a drug discovery company intended to accelerate the development of biologics through in-silico design and optimization. The company's platform offers computational tools for protein structure prediction, interaction analysis, and developability assessment, enabling customers to identify and optimize promising drug candidates faster and with reduced costs compared to traditional lab-based methods.